OpenResearchAlpha

Clinical Journal of the American Society of Nephrology · 6 Nov 2026

suPAR Is Associated with Progressive Albuminuria in Type 1 Diabetes

Anis Ismailh-index 4, Alexi Vasbinder, Theresa Farhat, Bobby Bobby, Ramya Elangovan, Christina Hutten, Iman Shaikh, Pennelope Kunkle, Alessandro Doria, Rodica Pop-Busuih-index 66, Salim S. Hayek, on behalf of the PERL Study Group

0
Citations
no database records one yet
0
Citations in 2026
so far
66
Leading author's h-index
Rodica Pop-Busui, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Background and Objectives Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived glycoprotein implicated in chronic kidney disease (CKD) and glomerulopathy. suPAR predicts CKD progression, but whether it is associated with longitudinal albuminuria worsening, including in patients without established albuminuria, is untested in diabetic kidney disease (DKD). We examined this in type 1 diabetes using albumin excretion rate (AER) trajectory. Design, Setting, Participants, & Measurements Post hoc analysis of 506 participants with a single baseline suPAR measurement from the PERL trial, a 3-year multicenter randomized controlled trial in type 1 diabetes with early-to-moderate DKD. Linear mixed models estimated suPAR’s association with AER and iohexol-measured glomerular filtration rate (iGFR) trajectories. Structural equation modeling assessed whether albuminuria level accounted for the association between suPAR and iGFR decline. Results Mean age was 51 years, 34% female, diabetes duration 35 years, iGFR 68 mL/min/1.73 m 2 , median AER 44 μg/min, and median suPAR 3.43 ng/mL. Each suPAR doubling was associated with 11.6% per year additional AER increase (P<0.001), with a dose-response across quartiles and robust to sensitivity analyses. Time-lagged analysis confirmed the association with subsequent AER worsening (P=0.004). Among 125 eGFR-decline qualifiers (predominantly normoalbuminuric), higher suPAR was associated with accelerated AER worsening (+13.1%/yr per doubling, P=0.005; +11.7%/yr in the 101 normoalbuminuric), although none crossed the proteinuria threshold. suPAR was also associated with AER category progression (HR 1.61, P=0.002) and ≥40% eGFR loss (HR 1.86, P=0.01). suPAR was not independently associated with GFR slope (total effect P=0.49); its association with lower GFR was accounted for by albuminuria level (indirect effect −0.59 mL/min/yr per doubling, P<0.001). Conclusions suPAR was independently associated with progressive albuminuria worsening in type 1 diabetes with DKD, including accelerated worsening among normoalbuminuric patients. These associations are consistent with suPAR marking active podocyte injury and support its evaluation for early risk stratification.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Rodica Pop-Busui has the highest h-index among the authors (66).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (12)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.